Microcrystalline cellulose is a partially depolymerized cellulose that can be commonly used as an excipient in pharmaceutical formulations. It is produced from a variety of pure cellulose sources like cotton linters and wood pulp via an alkaline treatment process which results in a white, odorless, crystalline powder. As MCC is chemically inert and stable across a wide range of temperatures, it is highly favored as a binding agent, diluent, suspension agent, and tableting aid in tablets, capsules, and other dosage forms. With advantageous properties like high compression ability, desirable flow characteristics, and low moisture absorption, microcrystalline cellulose has emerged as a versatile pharmaceutical excipient for use in numerous drug delivery systems.
Market Dynamics:
The global microcrystalline cellulose market is projected to witness significant growth over the forecast period owing to various drivers such as rising generic drug production, increasing pharmaceutical R&D investments, and growth of the oral drug delivery segment. Additionally, the ability of MCC to reduce production costs for drug manufacturers by enabling product miniaturization and high-speed tableting is also fueling its demand. However, price fluctuations of raw materials may pose a hindrance to the market expansion. On the other hand, the growing preference for excipient outsourcing over in-house manufacturing as well as innovations in specialized grades of MCC for controlled release formulations present lucrative opportunities for market players.
Key Features of the Study:
- This report provides an in-depth analysis of the global microcrystalline cellulose market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global microcrystalline cellulose market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, Chemfield Cellulose, Roquette Frères, and Sigachi Industries Limited.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global microcrystalline cellulose market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Detailed Segmentation-
- By Source Type:
- Wood Based
- Non-wood Based
- By End Use Industry:
- Pharmaceutical
- Food & Beverages
- Cosmetics & Personal Care
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Huzhou City Linghu Xinwang Chemical Co., Ltd.
- Rayonier Advanced Materials
- DFE Pharma
- Mingtai Chemical Co., Ltd
- JRS Pharma
- Asahi Kasei Corporation
- Dupont
- Avantor Inc.
- Sigachi Industries Pvt. Ltd
- Foodchem International Corporation
- Quadra Chemicals
- Maple Biotech Pvt. Ltd.
- Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
- Accent Microcell Pvt. Ltd.
- RanQ
- Chemfield Cellulose
- Roquette Frères
- Sigachi Industries Limited